Issue 2, 2011

Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis

Abstract

Detailed molecular phenotyping gives insight into disease mechanisms and can individualize medical practice for improved risk assessment and treatment. We show in an epidemiological study (n = 4309) that the multi-metabolic profiles obtained by serum NMR metabonomics inherently associate with the extent of atherosclerosis already in preclinical stages. Data-driven analysis of the spectral profiles of healthy, young adults revealed three distinct metabolic phenotypes associated with high carotid intima-media thickness (IMT), a surrogate marker of cardiovascular disease. The phenotypes were characterized by varying combinations of well-known metabolic disturbances like elevated VLDL and LDL and low HDL levels. Low IMT was also associated with distinct metabolic phenotypes with lipoprotein as well as other biochemical characteristics partly opposing those found for the high IMT phenotypes. Profiles of low-molecular-weight metabolites quantified from the experimentation were also characteristic for the metabolic phenotypes and substantiate developments toward the use of multi-metabolic risk phenotypes. The methodology can be taken as a direct extension for the routine analytics used for the risk assessment of atherosclerosis; quantification of metabolites will complement and might even replace conventional lipid measurements. Serum NMR metabonomics is therefore anticipated as a rational option for comprehensive cardiovascular risk assessment.

Graphical abstract: Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis

Supplementary files

Article information

Article type
Paper
Submitted
22 Jun 2010
Accepted
05 Oct 2010
First published
05 Nov 2010

Mol. BioSyst., 2011,7, 385-393

Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis

P. Würtz, P. Soininen, A. J. Kangas, V. Mäkinen, P. Groop, M. J. Savolainen, M. Juonala, J. S. Viikari, M. Kähönen, T. Lehtimäki, O. T. Raitakari and M. Ala-Korpela, Mol. BioSyst., 2011, 7, 385 DOI: 10.1039/C0MB00066C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements